Treatment Outcomes with Pomalidomide (POM) in Combination with Low-Dose Dexamethasone (LoDex) in Patients with Relapsed and Refractory Multiple Myeloma (RRMM) and Del(17p13) and/or t(4;14)(p16;q32) Cytogenetic Abnormalities Who Have Received Prior Therapy with Lenalidomide (LEN) and Bortezomib (BORT)

Paul G Richardson,Andrzej Jakubowiak,Nizar J Bahlis,David S Siegel,Christine I Chen,Min Chen,Mohamed Zaki,Gail Larkins,Kenneth C Anderson

doi:10.1182/blood.v120.21.4053.4053

Treatment Outcomes with Pomalidomide (POM) in Combination with Low-Dose Dexamethasone (LoDex) in Patients with Relapsed and Refractory Multiple Myeloma (RRMM) and Del(17p13) and/or t(4;14)(p16;q32) Cytogenetic Abnormalities Who Have Received Prior Therapy with Lenalidomide (LEN) and Bortezomib (BORT)

Paul G Richardson, Andrzej Jakubowiak + Show 7 more

https://doi.org/10.1182/blood.v120.21.4053.4053

Copy DOI

Export

Save

Cite

Journal: Blood	Publication Date: Nov 16, 2012
Citations: 13

Affiliation: Dana-Farber Cancer Institute, University of Chicago Medical Center, University of Calgary, Hackensack University Medical Center, Princess Margaret Cancer Centre, Emory University

#Mos For Pts #High-risk Cytogenetic Profiles #Relapsed And Refractory Multiple Myeloma #Speakers Bureau #High-risk Pts #High-risk Cytogenetics #Advisory Board #Relapsed And Refractory Multiple Myeloma Pts #Pomalidomide #Overall Median Duration Of Response

Abstract
Full-Text
Similar Papers

Abstract

Listen

Treatment Outcomes with Pomalidomide (POM) in Combination with Low-Dose Dexamethasone (LoDex) in Patients with Relapsed and Refractory Multiple Myeloma (RRMM) and Del(17p13) and/or t(4;14)(p16;q32) Cytogenetic Abnormalities Who Have Received Prior Therapy with Lenalidomide (LEN) and Bortezomib (BORT)

Full Text

Published Version

Check institute access

Open DOI Link

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Blood

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.

R Discovery Prime